BackJazz Pharmaceuticals plc Overview
Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc Target Price

Analysts' average 12-month price target for Jazz Pharmaceuticals plc is $290.

Get informed when a big investor buys or sells

+ Follow

Share Price

$240.37

Average Target Price

$293.6122.1% upside

28 analysts in the last 4 months

High: $337 | Low: $260

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-21Morgan Stanley$31430.6% upsideOpen
2026-10-08RBC Capital$29623.1% upsideOpen
2026-10-07Truist Financial$28619% upsideOpen
2026-09-24Goldman Sachs$33740.2% upsideOpen
2026-09-11UBS$33740.2% upsideOpen
2026-09-10Barclays$27112.7% upsideOpen
2026-08-28RBC CapitalLeonid Timashev$29924.4% upsideOpen
2026-08-26RBC CapitalLeonid Timashev$27715.2% upsideOpen
2026-08-26Truist FinancialGregory Renza$28116.9% upsideOpen
2026-08-26Morgan Stanley$32234% upsideOpen
2026-08-26Needham$31029% upsideOpen
2026-08-26Canaccord GenuityGary Newman$30024.8% upsideOpen
2026-08-26Deutsche BankDavid Hoang$30024.8% upsideOpen
2026-08-11Morgan Stanley$28317.7% upsideOpen
2026-08-04Deutsche Bank$28719.4% upsideOpen
2026-08-04Truist Financial$30024.8% upsideOpen
2026-08-04Morgan Stanley$28016.5% upsideOpen
2026-08-04Truist Financial$2649.8% upsideOpen
2026-08-04NeedhamAmi Fadia$29221.5% upsideOpen
2026-08-04UBS$31531% upsideOpen
2026-08-04Wells Fargo$30024.8% upsideOpen
2026-08-04Stifel Nicolaus$27514.4% upsideOpen
2026-08-04Piper Sandler$31029% upsideOpen
2026-08-04Robert W. Baird$28016.5% upsideOpen
2026-08-04Barclays$27012.3% upsideOpen
2026-07-16Canaccord GenuityGary Nachman$29020.6% upsideOpen
2026-07-14Wells Fargo$28518.6% upsideOpen
2026-07-14Barclays$2608.2% upsideOpen
2026-07-09Deutsche Bank$27012.3% upsideOpen
2026-07-07Truist FinancialGregory Renza$2545.7% upsideOpen
2026-06-09Truist FinancialGregory Renza$2566.5% upsideOpen
2026-05-27Barclays$2535.3% upsideOpen
2026-05-22Piper Sandler$30125.2% upsideOpen
2026-05-21Bernstein$2294.7% downsideOpen
2026-05-19UBSAshwani Verma$30727.7% upsideOpen
2026-05-07Morgan StanleySean Laaman$2451.9% upsideOpen
2026-05-06Raymond JamesTiago Fauth$2390.6% downsideOpen
2026-05-06Robert W. Baird$2524.8% upsideOpen
2026-05-06BarclaysEtzer Darout$2342.7% downsideOpen
2026-04-20BarclaysEtzer Darout$2256.4% downsideOpen
2026-04-10Raymond James$2275.6% downsideOpen
2026-03-09BarclaysEtzer Darout$2246.8% downsideOpen
2026-01-12NeedhamAmi Fadia$2352.2% downsideOpen
2026-01-08Morgan StanleySean Laaman$2256.4% downsideOpen
2025-12-10Piper SandlerDavid Amsellem$2198.9% downsideOpen
2025-11-24UBSAshwani Verma$18821.8% downsideOpen
2025-11-17RBC Capital$19419.3% downsideOpen
2025-11-17Morgan StanleySean Laaman$20514.7% downsideOpen
2025-10-24Morgan Stanley$18323.9% downsideOpen
2025-10-22Wells Fargo$17029.3% downsideOpen

Jazz Pharmaceuticals plc (JAZZ) FAQ

The latest target price for JAZZ is $290. Investors often review this figure alongside Jazz Pharmaceuticals plc's historical trend and sector peers before judging valuation or financial health.

Jazz Pharmaceuticals plc trades near $240.37 while the consensus target sits at $290 (22.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting JAZZ's target price ($290), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Jazz Pharmaceuticals plc's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.